- Article metrics
- Last updated: Sat, 14 Feb 2026 19:22:47 Z
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)
Access & Citations
-
- 761
- Article Accesses
-
- 8
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
